Nuclear medicine in neurology and psychiatry
暂无分享,去创建一个
[1] D. Costa,et al. Dementia with Lewy bodies: Preliminary data on clinical, pathological and FP-CIT SPET correlations , 1999 .
[2] J. Moringlane,et al. Evaluation of l-3-[123I]iodo-α-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy , 1999, European Journal of Nuclear Medicine.
[3] A. Schapira. Science, medicine, and the future: Parkinson's disease. , 1999, BMJ.
[4] P. Barber,et al. Spontaneous reperfusion after ischemic stroke is associated with improved outcome. , 1998, Stroke.
[5] Kaj Blennow,et al. It's getting better all the time , 1998, The Lancet.
[6] Otto Muzik,et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography , 1998, Nature Medicine.
[7] M. Raichle. Imaging the mind. , 1998, Seminars in nuclear medicine.
[8] N. Volkow,et al. A novel strategy for the treatment of cocaine addiction , 1998, Synapse.
[9] Robert B. Innis,et al. Iodine-123-β-CIT and Iodine-123-FPCIT SPECT Measurement of Dopamine Transporters in Healthy Subjects and Parkinson's Patients , 1998 .
[10] I. Wilkinson,et al. Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS. , 1998, Sexually transmitted infections.
[11] P. Ewan. Prevention of peanut allergy , 1998, The Lancet.
[12] J. Martinot,et al. Binding of antipsychotic drugs to cortical 5-HT2A receptors: a PET study of chlorpromazine, clozapine, and amisulpride in schizophrenic patients. , 1998, The American journal of psychiatry.
[13] V Hachinski,et al. The effect of different diagnostic criteria on the prevalence of dementia. , 1997, The New England journal of medicine.
[14] R. Kerwin,et al. Serotonin: 5-HT2A receptor occupancy in vivo and response to the new antipsychotics olanzapine and sertindole , 1997, British Journal of Psychiatry.
[15] Peter J Ell,et al. Limbic selectivity of clozapine , 1997, The Lancet.
[16] Schwartz,et al. Neuroimaging in Closed Head Injury. , 1997, Seminars in Clinical Neuropsychiatry.
[17] S. J. Gatley,et al. Relationship between subjective effects of cocaine and dopamine transporter occupancy , 1997, Nature.
[18] A. Elliott,et al. First SPET images of glutamate (NMDA) receptor activation in vivo in cerebral ischaemia , 1997, Nuclear medicine communications.
[19] G. Goodwin,et al. Functional imaging, affective disorder and dementia. , 1996, British medical bulletin.
[20] J. Mueller‐Brand,et al. Brain SPECT findings in late whiplash syndrome , 1995, The Lancet.
[21] B L Holman,et al. Brain single‐photon emission computed tomography* , 1994, Neurology.
[22] J. Laidlaw,et al. A Textbook of Epilepsy , 1993 .
[23] G. Marchal,et al. PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to outcome , 1993, The Lancet.
[24] Christer Halldin,et al. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients , 1993, Biological Psychiatry.
[25] R. M. Murray,et al. Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia , 1992, The Lancet.
[26] G. Sedvall,et al. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. , 1992, Archives of general psychiatry.
[27] S. Gilman,et al. Advances in neurology (2). , 1992, The New England journal of medicine.
[28] P. Anslow,et al. Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[29] T. Gasser,et al. 123I‐iodobenzamide‐SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism , 1992, Neurology.
[30] D. Cikrit,et al. Carotid artery disease: evaluation with acetazolamide-enhanced Tc-99m HMPAO SPECT. , 1992, Radiology.
[31] C. Rowe,et al. Patterns of postictal cerebral blood flow in temporal lobe epilepsy , 1991, Neurology.
[32] P. Ell,et al. 99TCm-HMPAO SPECT studies in traumatic intracerebral haematoma. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[33] D. Brooks. PET: its clinical role in neurology. , 1991, Journal of neurology, neurosurgery, and psychiatry.
[34] C. Pozzilli,et al. Predictive value of brain perfusion single-photon emission computed tomography in acute ischemic stroke. , 1990, Stroke.
[35] S. Peroutka,et al. Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency. , 1980, The American journal of psychiatry.
[36] N. Volkow,et al. Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of "high". , 1999, The Journal of pharmacology and experimental therapeutics.
[37] J. Mountz,et al. Prognostication of recovery following stroke using the comparison of CT and technetium-99m HM-PAO SPECT. , 1990, Journal of Nuclear Medicine.
[38] Ward Aa. Perspectives for surgical therapy of epilepsy. , 1983 .